Synergism of Cyclin-Dependent Kinase Inhibitors with Camptothecin Derivatives in Small Cell Lung Cancer Cell Lines

Author： Hamilton Gerhard   Klameth Lukas   Rath Barbara   Thalhammer Theresia  

Publisher： MDPI

E-ISSN： 1420-3049|19|2|2077-2088

ISSN： 1420-3049

Source： Molecules, Vol.19, Iss.2, 2014-02, pp. : 2077-2088

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines

By Hamilton Gerhard  

Marine Drugs, Vol. 12, Iss. 3, 2014-03 ,pp. : 1377-1389

MDPI

Access to resources Recommend Favorite

Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

By Ulivi Paola  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1186-1186

MDPI

Access to resources Recommend Favorite

Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine

By Lu Fang   Luo Ganggang   Qiao Liansheng   Jiang Ludi   Li Gongyu   Zhang Yanling  

Molecules, Vol. 21, Iss. 9, 2016-09 ,pp. : 1259-1259

MDPI

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey

By Mariaule Gaëlle   Belmont Philippe  

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 14366-14382

MDPI

Access to resources Recommend Favorite

Several Human Cyclin-Dependent Kinase Inhibitors, Structurally Related to Roscovitine, As New Anti-Malarial Agents

By Houzé Sandrine   Hoang Nha-Thu   Lozach Olivier   Le Bras Jacques   Meijer Laurent   Galons Hervé   Demange Luc  

Molecules, Vol. 19, Iss. 9, 2014-09 ,pp. : 15237-15257

MDPI

Access to resources Recommend Favorite